602
Participants
Start Date
March 14, 2017
Primary Completion Date
August 21, 2023
Study Completion Date
August 21, 2023
Pitavastatin
One tablet (4 mg) taken once daily, orally with or without food for the entire time participant was in REPRIEVE follow-up.
Placebos
One tablet taken once daily, orally with or without food for the entire time participant was in REPRIEVE follow-up.
Weill Cornell Chelsea CRS (7804), New York
Weill Med. College of Cornell Univ., The Cornell CTU -Chelsea (7803), New York
Columbia Physicians and Surgeons CRS (30329), New York
University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787), Rochester
Pittsburgh CRS (1001), Pittsburgh
Hosp. of the Univ. of Pennsylvania CRS (6201), Philadelphia
Johns Hopkins University CRS (201), Baltimore
Greensboro CRS (3203), Greensboro
Unc Aids Crs (3201), Chapel Hill
Alabama CRS (31788), Birmingham
Vanderbilt Therapeutics CRS (3652), Nashville
The Ohio State Univ. AIDS CRS (2301), Columbus
Case CRS (2501), Cleveland
Univ. of Cincinnati CRS (2401), Cincinnati
2701 Northwestern University CRS, Chicago
Rush Univ. Med. Ctr. ACTG CRS (2702), Chicago
Washington University CRS (2101), St Louis
Trinity Health and Wellness Center CRS (31443), Dallas
Houston AIDS Research Team (HART) CRS (31473), Houston
University of Colorado Hospital CRS (6101), Aurora
University of California, Los Angeles CARE Center CRS (601), Los Angeles
Harbor-UCLA Med. Ctr. CRS (603), Torrance
Ucsd, Avrc Crs (701), San Diego
Ucsf Aids Crs (801), San Francisco
University of Washington AIDS CRS (1401), Seattle
University of Southern California (1201), Los Angeles
Massachusetts General Hospital (MGH) CRS (101), Boston
Brigham and Women's Hosp. ACTG CRS (107), Boston
New Jersey Medical School Clinical Research Center CRS (31786), Newark
The Miriam Hospital (TMH) ACTG CRS (2951), Providence
Puerto Rico-AIDS CRS (5401), San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
National Institute on Aging (NIA)
NIH
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
NETWORK